Display options
Cite
Castelli MR, Saint CA, Nuziale BT, et al. Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial. Hosp Pharm. 2017;52(7):496-501doi: 10.1177/0018578717721105.
Castelli, M. R., Saint, C. A., Nuziale, B. T., Stern, G. M., Stacy, Z. A., Crannage, A. J., & Pitlick, J. M. (2017). Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial. Hospital pharmacy, 52(7), 496-501. https://doi.org/10.1177/0018578717721105
Castelli, Michelle R, et al. "Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial." Hospital pharmacy vol. 52,7 (2017): 496-501. doi: https://doi.org/10.1177/0018578717721105
Castelli MR, Saint CA, Nuziale BT, Stern GM, Stacy ZA, Crannage AJ, Pitlick JM. Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial. Hosp Pharm. 2017 Jul;52(7):496-501. doi: 10.1177/0018578717721105. Epub 2017 Jul 25. PMID: 29276279; PMCID: PMC5735710.
Copy Download .nbib Format: NLM
Share it on

Hosp Pharm. 2017 Jul;52(7):496-501. doi: 10.1177/0018578717721105. Epub 2017 Jul 25.

Effect of a Rivaroxaban Patient Assistance Kit (R-PAK) for Patients Discharged With Rivaroxaban: A Randomized Controlled Trial.

Hospital pharmacy

Michelle R Castelli, Catherine A Saint, Brandon T Nuziale, Gretchen M Stern, Zachary A Stacy, Andrew J Crannage, Jamie M Pitlick

Affiliations

  1. University of California San Diego Health, La Jolla, CA, USA.
  2. Mercy Hospital, St. Louis, MO, USA.
  3. Oregon School of Pharmacy, Pacific University, Hillsboro, OR, USA.
  4. Brigham and Women's Hospital, Boston, MA, USA.
  5. St. Louis College of Pharmacy, St. Louis, MO, USA.
  6. Drake University College of Pharmacy and Health Sciences, Des Moines, IA, USA.

PMID: 29276279 PMCID: PMC5735710 DOI: 10.1177/0018578717721105

[No abstract available.]

Keywords: anticoagulant; discharge counseling; patient education; rivaroxaban; transitions of care

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Stacy serves

References

  1. Health Qual Life Outcomes. 2012 Sep 26;10:120 - PubMed
  2. J Am Heart Assoc. 2016 Feb 23;5(2): - PubMed
  3. Chest. 2016 Feb;149(2):315-352 - PubMed
  4. Br J Haematol. 2016 Jul;174(1):30-42 - PubMed
  5. JAMA. 2015 Apr 14;313(14):1443-50 - PubMed
  6. Value Health. 2005 Nov-Dec;8 Suppl 1:S9-S24 - PubMed

Publication Types